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Mycobacterium tuberculosis is a high GC Gram-positive member of
the actinobacteria. The mycobacterial cell wall is composed of a
complex assortment of lipids and is the interface between the
bacterium and its environment. The biosynthesis of fatty acids
plays an essential role in the formation of cell wall components, in
particular mycolic acids, which have been targeted by many of the
drugs used to treat M. tuberculosis infection. M. tuberculosis has
250 genes involved in fatty acid metabolism, a much higher
proportion than in any other organism. In silico methods have been
used to compare the genome of M. tuberculosis CDC1551 to a
database of 58 complete bacterial genomes. The resulting align-
ments were scanned for genes specifically involved in fatty acid
biosynthetic pathway I. Phylogenetic analysis of these alignments
was used to investigate horizontal gene transfer, gene duplication,
and adaptive evolution. It was found that of the eight gene
families examined, five of the phylogenies reconstructed suggest
that the actinobacteria have a closer relationship with the -
proteobacteria than expected. This is either due to either an
ancient transfer of genes or deep paralogy and subsequent reten-
tion of the genes in unrelated lineages. Additionally, adaptive
evolution and gene duplication have been an influence in the
evolution of the pathway. This study provides a key insight into
how M. tuberculosis has developed its unique fatty acid synthetic
abilities.
The Mycobacterium genus comprises70 species and includesthe human pathogens Mycobacterium tuberculosis and My-
cobacterium leprae. M. tuberculosis is a member of the actinobac-
teria and is a Gram-positive pathogenic bacterium. It is esti-
mated that over the next 25 years, 40 million people will die from
tuberculosis (1). The completion of many bacterial genome-
sequencing projects has aided the study of these diseases in the
hope of finding their mechanisms of evading host immune
systems and to try to explicate their metabolic pathways. The
complete genomes of the laboratory strain M. tuberculosis
H37Rv (2) and a recent clinical isolate M. tuberculosis CDC1551
(3) have been sequenced. These two genomes display 99%
identity at the nucleotide level, and the majority of differences
between the two genomes are single-nucleotide changes, of
which there are 1,000 (4). It has been shown that the acti-
nobacteria form a monophyletic group on the prokaryote phy-
logenetic tree, and that they group beside the Thermus
Deinococcus and Cyanobacteria clade (5). The -, -, and
-proteobacteria form a monophyletic grouping also. There is no
suggestion of any specific relationship between these two groups.
Comparative genomic methods have allowed for the investi-
gation of regularities and differences observed across species at
the DNA level (6). Bacteria increase their DNA content by
horizontal gene transfer (HGT) and gene duplication, yet there
is a selective pressure to minimize genome size to promote
efficiency or competitiveness during replication (7). Therefore
gene loss by either large deletion events or point or frameshift
mutations serves to counterbalance the increase in gene number
and removes harmful mutations. HGT brings new genes into the
genome that are either homologous to existing genes or entirely
new sequence families (8). The potential for acquiring and
replacing an existing gene generally decreases with the phylo-
genetic distance between the donor and recipient lineages, and
an acquired gene or gene segment is more likely to be beneficial
if it has some properties similar to the recipient genome (8). It
is reasonable to say that we are still naı¨ve on this point, and the
incidence of HGT in microbial consortia is unknown.
It has been shown that there may be a core group of genes that
remain more closely associated over a long period through
evolution than the rest of the genes in a genome (9). Neverthe-
less, there is a growing awareness of the role of HGT in the
evolution and speciation of microorganisms (10). It is now
recognized that HGT has shaped the microbial genescape (11),
and ‘‘it is the major, if not the sole, evolutionary source of true
innovation: novel enzymatic pathways, novel membrane trans-
porter capacities, novel energetics’’ (12).
Adaptive evolution (positive Darwinian selection) in protein-
coding genes is thought to be an ephemeral event, frequently
leading to the generation of novel function, and is generally
thought to be the result of selective pressures favoring a high
level of replacement substitutions (13–15). Therefore, positive
selection is natural selection that favors amino acid change (16).
Numerous methods have been used to detect positive selection
(17–19), and there have been an abundance of cases where this
effector of change has been shown to have acted on key genes,
e.g., the Colubine primate lysozyme proteins (20, 21).
The M. tuberculosis genome contains 250 enzymes involved
in fatty acid metabolism in comparison with the Escherichia coli
genome that contains50 such enzymes (2). It is intriguing that
M. tuberculosis needs so many more of these enzymes when the
genomes of these two organisms are so similar in size. Fatty acid
metabolism in M. tuberculosis is vital to the survival of the
bacterium in the host, because its mycolic acids, produced from
elongated fatty acids, form a protective lipid layer in the cell wall,
and it is this lipid layer that has proven most interesting from a
drug target point of view (22). It is therefore necessary that the
intricate pathways and many enzymes involved are explored to
determine why fatty acid metabolism is so important to this
bacterium and specifically where the genes came from.
There are three possibilities that may explain the large number
of enzymes involved in fatty acid metabolism in M. tuberculosis:
birth of genes, gene duplication (paralogy), and HGT (either
recent or ancient). In bacteria such as Neisseria meningitidis,
genetic exchange is so frequent that lineage boundaries are
difficult to distinguish (23). In contrast, the M. tuberculosis
complex has been thought until recently to owe its genome
plasticity to insertion and deletion events that may have arisen
due to insertion sequence-triggered events or slipped-strand
mispairing during replication (24). It has been suggested, how-
ever, that M. tuberculosis has the highest number of eukaryotic–
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prokaryotic interkingdom gene fusions of all sequenced bacterial
genomes (25), and it has even been proposed that 19 genes of
eukaryotic origin have been found in the M. tuberculosis genome
(26). If M. tuberculosis has indeed obtained genes from eu-
karyotes in the past, it would seem reasonable to speculate that
the genome may also have obtained genes from other pro-
karyotes by HGT. For this reason, it was decided to examine
some of these enzymes from the fatty acid biosynthetic pathway
and determine whether indeed they were recent additions to the
genome by means of HGT.
Knowledge of the biochemistry of fatty acid biosynthetic
pathways I and II for M. tuberculosis is incomplete at present due
in part to the difficulty in culturing this slow-growing bacterium.
According to the Kyoto Encyclopedia of Genes and Genomes
(KEGG) database (27), there are two discrete enzyme systems
in the biosynthesis of fatty acids in mycobacteria, namely fatty
acid synthase (FAS) I and II (2, 27, 28). The FAS I system
consists of a single polypeptide with multiple catalytic activities
that creates short precursors for elongation by other fatty acid
systems (2). The FAS II system includes a host of enzymes
involved in the elongation of substrates bound to an acyl-carrier
protein to produce mycolic acids (2). The FAS II system for
H37Rv has been well studied, because it contains the enzymes
involved in the production of the cell wall mycolic acids (27, 28).
Fig. 1 contains a simplified diagram of the KEGG pathway I
showing all of the genes from CDC1551 involved in the biosyn-
thesis and elongation of fatty acids. Some of the enzymes in this
pathway produce mycolic acids (2), and therefore these enzymes
are interesting to study, because the cell wall is the focal point
of interest when it comes to interaction between the host cell and
the bacterium.
The focus of this research has been to try to ascertain why the
M. tuberculosis genome possesses so many genes involved in fatty
acid metabolism. Another challenge is to evaluate whether the
bacterium has always possessed this many genes for this function,
or whether these genes were acquired from elsewhere. It is also
important to determine whether gene duplication events played
a significant role in expanding the repertoire of genes involved
in fatty acid metabolism. Considering it has been shown that
adaptive evolution can occur after duplication (29, 30), we
sought to examine whether this might happen after perturbation
of this pathway, following either duplication or gene acquisition.
Materials and Methods
A database of complete genome sequences for 58 organisms,
including 9 Archaea, 30 Gram-negative bacteria, and 19 Gram-
positive bacteria, was assembled by downloading the relevant
information from www.ncbi.nlm.nih.gov, www.sanger.ac.uk, or
www.tigr.org. The Kyoto Encyclopedia of Genes and Genomes
database (28) was searched for the genes encoding the enzymes
involved in fatty acid biosynthetic pathway I for the CDC1551
strain. BLAST (31) was used to perform a search of each
CDC1551 gene against the database. Putative homologues with
e values 1020 were retrieved from the database and aligned
by using CLUSTALW (32). These alignments were corrected for
obvious alignment ambiguity by using SEAL, Ver. 2.0a9 (http:
evolve.zoo.ox.ac.uksoftwareSe-Almain.html). The align-
ments are available on request from the authors.
To assess the incidence of horizontal gene transfer, robust
hypotheses of phylogenetic relationships were generated by
using the corrected alignments. These hypotheses were con-
structed with the Bayesian framework implemented in MR.
BAYES 2.01 (33). For the Bayesian analysis clade, probability
values were generated by using the sumt command. Consensus
trees were generated with PAUP* 4.0b10 (PPC) (34).
Analyses of adaptive evolution were carried out by using the
likelihood ratio test (LRT) methods described by Yang (35–38).
LRT is used to evaluate nested models of sequence evolution.
Some models are more parameter-rich extensions of other
models, and when this is the case, an LRT may be performed
with twice the log-likelihood difference being compared with a
2 distribution with the degrees of freedom equal to the differ-
ence in the number of parameters between the two models (for
a more complete description, see ref. 39). The results are
presented in Table 1, which is published as supporting informa-
tion on the PNAS web site, www.pnas.org. These methods
involve the estimation of dN:dS ratios (nonsynonymous to
synonymous substitution ratio, termed ) by using maximum
likelihood estimation of parameters on a phylogenetic tree.
Models that either restrict or allow  to vary across sites
(site-rate models with a variety of ‘‘classes’’ of sites) or across
sites and lineages (branch-site models) were used. Finally, when
the maximum likelihood optimization of the parameters is
complete, an empirical Bayes approach is used to infer which
class a site is most likely from (40). Those sites with a high
probability of coming from a class of sites with a high  are most
likely to be under positive selection. The models of Yang and
Nielsen (39) have been used in this paper, with the same
nomenclature being preserved.
To investigate the possibility that putative HGT genes display
a synonymous codon usage pattern that is unusual compared
Fig. 1. Simplified diagram of the Kyoto Encyclopedia of Genes and Genomes fatty acid biosynthetic pathway I indicating the EC numbers of the enzymes
involved and the number of sequences in each alignment. The colored boxes indicate that an alignment has been analyzed for this step of the pathway, and
the letters of the alphabet (A–G) in order correspond to the tree diagram constructed for that alignment (see Figs. 2–5 and 7–9).







with the rest of the genome, an analysis of variation in synony-
mous codon usage was carried out by using GCUA (40). A
correspondence analysis of raw codon counts was carried out,
with the first four principal axes being used to evaluate synon-
ymous codon usage patterns. Only the first two axes are shown
in Fig. 6, which is published as supporting information on the
PNAS web site.
Results
Fig. 1 illustrates the enzymes involved in fatty acid biosynthetic
pathway 1 and details the order chronologically in which the
alignments for these enzymes will be examined.
The tree illustrated in Fig. 2 was constructed from the
acetyl-CoA carboxylase carboxyl transferase -subunit. The
topology of this tree is unusual and suggests either that most
actinobacteria are more closely related to the proteobacteria
than previously thought or they acquired genes from an ancestor
of the -proteobacteria. Most of the actinobacterial sequences
form a sister-group relationship with genes from -proteobac-
teria such as Sinorhizobium meliloti, Mezorhizobium loti, and
Caulobacter crescentus with 99% clade credibility support. The
low GC Gram-positive bacteria are located elsewhere on the
tree. The exception is a sequence from Streptomyces coelicolor
(an actinobacterium) that, unusually, does not group with the
actinobacteria but instead forms part of a separate clade with
Bacillus halodurans and Deinococcus radiodurans. Therefore in
this first step of the pathway, we appear to have significant
support for the ancient acquisition of this gene from the -pro-
teobacteria or a closer relationship than previously believed
between the -proteobacteria and the actinobacteria.
Given that this dataset of 43 sequences is sufficiently small to
perform a number of likelihood ratio tests for heterogeneity of
selective pressures across sites and lineages, we performed a
number of analyses for evidence of adaptive evolution. For the
branch-site models, we marked the lineage leading to the two M.
tuberculosis sequences. We tested a variety of models against null
hypotheses of simpler models and found that two models were
interesting insofar as they were significantly better fit to the data
than the simpler models. These were models B and 7. In both
cases, these models suggest that the majority of sites are under
strong purifying selection. In the case of model 7, which is a
site-rate model, it suggests that all sites in the alignment are
under strong purifying selection. However, when the branch
leading to the M. tuberculosis sequences is marked as a ‘‘fore-
ground’’ branch, the likelihood is significantly greater (P 
0.005) than the null model (model 3, k  2), and as many as
20.5% of sites on this branch are hypothesized to be under strong
positive selection for change (  82.8). Using Bayesian esti-
mation, eight sites are likely to be in the class of sites with an1
in the foreground lineage (P  0.95).
Moving to the next enzyme in the pathway, there are two genes
in the CDC1551 genome that perform this enzymatic function,
MT2576 and MT3384. A diagram of this tree is too large to
include here and is published as supporting information on the
PNAS web site. Fig. 7, which is published as supporting infor-
mation on the PNAS web site, indicates yet another example of
either an ancient horizontal gene transfer or perhaps deep
paralogy and differential retention of paralogues. There are four
regions of the tree in which we find actinobacteria. The top of the
tree houses a diverse group of low GC Gram-positive bacteria.
Three of the clades containing actinobacterial sequences are
closely related to proteobacterial sequences, specifically the
-proteobacteria. The fourth clade of actinobacteria have a sister
grouping with a sequence from Halobacterium (an Archaeon).
The Halobacterium gene groups with the actinobacteria with
100% clade credibility support and may suggest an interdomain
horizontal gene transfer event. It is unlikely that this represents
differential retention of ancient paralogues.
The third enzyme involved in this pathway is Malonyl CoA-
(acp) transacylase. Unusually, this alignment was actinobacteria
specific, containing only one gene from M. leprae, one from
H37Rv, one from CDC1551, and one from S. coelicolor. There-
fore it was not possible to construct a useful tree. However, this
is an interesting finding, because it appears that although other
bacterial species possess the gene for this enzyme, their genes are
not homologous to the actinobacterial genes.
The next part of the pathway relates to the cyclic elongation
of the fatty acids. The enzyme EC 2.3.1.41 in CDC1551, is
encoded by four genes: MT0557, MT2305, MT2306, and
MT3021.1. The first of these genes, MT0557, is annotated as a
3-oxoacyl (acp) synthase II. The alignment produced for this
family contains 51 sequences and appears to be distinct from the
alignments containing the other three genes. The tree (Fig. 3)
produced from this alignment provides evidence that once again
the actinobacterial homologues of this gene are more closely
related to the proteobacteria than would have been expected.
The actinobacterial clades reside within a large group of pro-
teobacteria. The grouping of the actinobacteria beside M. loti is
supported by 57% clade credibility. The S. coelicolor genes form
a clade with Pseudomonas aeruginosa, a -proteobacteria, and
this clade is supported by a 100% clade credibility value. This
alignment was small enough to perform analyses of adaptive
evolution. We used site-rate and branch-site models with the
lineage leading to the two Mycobacterium sequences marked as
a foreground branch. We did not detect signatures indicative of
adaptive evolution anywhere in this dataset.
The other genes corresponding to the enzyme EC 2.3.1.41 are
MT2305, MT2306, and MT3021.1, and one alignment was
generated that contained these genes and their homologues. One
of the most interesting observations in Fig. 8, which is published
as supporting information on the PNAS web site, was that there
was a large amount of Mycobacterium-specific gene duplication.
The region of the tree containing these duplications shows a
number of clades in which we exclusively find Mycobacterium
species, and there is evidence of several gene duplication events.
It is interesting to note that, even though the other actinobacteria
Fig. 2. Phylogenetic tree of the acetyl-CoA carboxylase, carboxyl transferase
-subunit, corresponding to Fig. 1A. The numbers on the branches are Bayes-
ian clade probabilities. The arrow indicates the branch that was analyzed for
signatures indicative of adaptive evolution.
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do feature in this region of the tree, their homologs have not
duplicated to the same extent as M. tuberculosis. Besides this very
large duplication of mycobacterial genes, there are three lesser
clades of actinobacteria. The clade at the top of the tree groups
the mycobacteria with an M. loti gene from the -proteobacteria,
suggesting that this may be a horizontal gene transfer event or
evidence for deep paralogy. It is interesting that this clade is
grouped in the middle of two clades of genes from Bacillus
subtilis, a low GC Gram-positive bacterium. Toward the bottom
of the tree, there is a clade of actinobacteria containing a gene
duplication of the mycobacteria and multiple homologs from S.
coelicolor. The closest clade to this contains -proteobacteria
and two S. coelicolor homologs. In this instance, perhaps the
-proteobacteria acquired the genes from the actinobacteria, or
again the closeness of the two groups on the tree could be due
to ancient artifacts.
The next stage of the elongation cycle involves the oxidoreduc-
tases (EC 1.1.1.100). There are five genes that correspond to this
EC number in CDC1551. Once again, one of the query genes
produced an alignment with homologues that were dissimilar to
the large alignment produced by the other four query genes. The
large alignment contained four of the five genes, MT0793,
MT1393, MT1530, MT3664, and all their homologues, and in
total, 366 sequences were used to construct the consensus tree
(Fig. 9, which is published as supporting information on the
PNAS web site). It appears to have been quite a promiscuous
gene, because the tree shows evidence of clades comprised of
mycobacteria with proteobacteria, Gram-negative bacteria
grouped with Archaea, Gram-positive bacteria with -proteo-
bacteria, and almost every combination of prokaryote possible.
It is possible that this gene is highly prone to HGT events. The
phylogenetic groupings do not appear to conform to those seen
when using the16S rRNA gene, for example.
The fifth gene, (MT3606) 3-oxoacyl-(acp)-reductase, con-
sisted of an alignment of 22 sequences. The resulting tree (Fig.
4) shows an example, once again, of a Mycobacterium-specific
gene duplication. This tree is also interesting, because there may
be evidence that the proteobacteria acquired genes from the
actinobacteria. C. crescentus and S. meliloti genes are grouped
with the actinobacteria with clade credibility support of 71%. P.
aeruginosa, a -proteobacterium, is grouped in the middle of the
actinobacteria with a clade credibility support value of 100%. An
alternative but less likely explanation may be that the genes are
closely related due to deep paralogy. The analyses of adaptive
evolution for this dataset indicate that there are lineage-specific
episodes of adaptive selection. The site-rate models all indicate
there is no category of site for which there is positive selection
across the tree. However, using the branch-site model, model B,
there is significant support for adaptive evolution on the branch
labeled in Fig. 4. In fact, it is estimated that a total of 14.6% of
sites are likely to be under positive selection on this lineage (
2.58, P  0.95).
The final enzyme found in the pathway is the enoyl (acp)
reductase (MT1531). The tree in Fig. 5 is distinctive in that is
does not appear to show any evidence of HGT. There is minimal
evidence of paralogy in this gene family, and the shape of the tree
does not indicate any specific relationship between the -pro-
teobacteria and the actinobacteria, despite the presence of
sequences from both sets of organisms on the tree. This is the
only case in the pathway where there is a monophyletic clade
of actinobacteria that group separately from the other -proteo-
bacteria, as we might expect. The actinobacteria group together
with a clade credibility support value of 100%, and there is very
high support (99% clade credibility support) for the grouping of
the -proteobacteria with other proteobacteria. This enzyme
shows no evidence of positive selection by using either site-rate
or branch-site models.
It has been shown in E. coli that genes thought to have been
acquired recently by the genome often display a codon prefer-
ence different than most other genes in the genome (41). To
Fig. 3. Phylogenetic tree inferred from the 3-oxoacyl-(acp) synthase III
genes. This tree corresponds to Fig. 1C. Numbers on internal branches indicate
clade credibility values for those internal branches where the values were
100. All unlabeled branches correspond to credibility values of 100. The
arrow indicates the branch that was analyzed for signatures indicative of
adaptive evolution.
Fig. 4. Phylogenetic tree inferred from 3-oxoacyl (acp) reductase genes. This
tree corresponds to Fig. 1F. The numbers on the internal branches are Bayesian
clade credibility values. The arrow indicates the branch that was analyzed for
signatures indicative of adaptive evolution.







examine whether these horizontally transferred genes display an
unusual codon usage, an analysis of variation in synonymous
codon usage in M. tuberculosis CDC1551 was carried out.
Correspondence analysis has already been performed for the
H37Rv strain (42), and our results concur with the authors’
findings. The results are shown in Fig. 6. The first axis explains
14% of the total inertia of the data, and the second axis explains
a further 8%. As can be seen, most of the variation in axis 1 is
due to a small number of outlier genes. It transpires that these
genes mostly belong to either the PE or PPE families of proteins,
as was found in the analysis of the H37Rv strain (42). The genes
from fatty acid pathway I do not display an unusual synonymous
codon usage. The codon usage of these genes is very similar to
most genes in the M. tuberculosis CDC1551 genome.
Discussion
Fatty acid biosynthesis is likely a very ancient pathway. The
relative ubiquity of fatty acid synthesis across all of the major
groups of organisms provides reasonable support for this hy-
pothesis. It might seem likely that in a similar way to translation
or replication, a mechanism of carrying out this function would
have been invented early in evolution, and the contemporary
operation of this pathway would have remained largely un-
changed. However, from the evidence of this study, we can see
that in the actinobacteria in general and in M. tuberculosis in
particular, this pathway has been changed significantly. Fatty
acid biosynthesis is an essential part of the M. tuberculosis
lifestyle with the genome containing 250 fatty acid metabo-
lizing enzymes.
In this study, we have shown that five protein families from the
fatty acid biosynthetic pathway group the actinobacteria with the
proteobacteria and specifically the -proteobacteria, suggesting
HGT. Another step in the pathway appears to be a de novo
invention by the actinobacteria, although greater sampling of
genomes will help clarify this situation. A further two gene
families have extensive levels of gene duplication. Evidence for
adaptive evolution has been found in two gene families, and only
one step in the pathway (Fig. 5) shows no evidence for gene
acquisition, duplication, or positive selection.
Many of the fatty acid biosynthesis genes in this study seem to
have been acquired from, or are more closely related than
expected to, the -proteobacteria (i.e., the rhizosphere, bacteria,
and relatives). On the one hand, this seems to be an unusual
situation, given the likelihood that this pathway existed in early
prokaryotes and is likely to have been fully functional possessing
most, if not all, of the genetic components to adequately
synthesize fatty acids. On the other hand, the closeness of the
relationship between the mycobacterial genes and the -
proteobacterial genes seems reasonable when one considers that
the majority of the members of the Mycobacterium genus are
soil-dwelling bacteria (43), and that most members of the
-proteobacteria are also soil dwellers, suggesting there has been
opportunity for these organisms to exchange genetic material.
It is more than likely that M. tuberculosis and the other actino-
bacteria had native copies of these enzymes, and they have been
replaced by HGT from proteobacteria.
The Malonyl CoA transacylase enzyme is almost a bottleneck
in one section of the cycle and is unique in this pathway, because
its gene is actinobacterium-specific. This enzyme function exists
in other bacterial species, but the genes responsible are not
homologous to the ones from the actinobacteria. Given its
central role in the pathway, it is most unusual to think that it was
invented late in evolution, and that this invention has replaced
the gene that was responsible for catalyzing this reaction. It is
also curious that there is no homolog in the Corynebacterium
glutamicum genome. If we consider this fact, along with the fact
that two other enzymatic functions in this pathway (EC 2.3.1.41
and EC 1.1.1.100) are carried out by separate groups of nonho-
mologous proteins, it seems likely that this pathway is evolving
in many ways apart from point mutation, and that turnover and
replacement of genes and gene families is characteristic of the
evolution of the pathway.
The position of all of these fatty acid synthesis genes in the M.
tuberculosis CDC1551 genome varies. Obviously the MT2303,
MT2305, and MT2306 genes lie very close to each other on the
genome, as do the MT1530 and MT1531 genes. It is possible that
these two groups of genes were ancient HGT events of either
single genes or an operon from another source. It must be noted,
however, that the results for MT2303 indicate that it is a
Mycobacterium-specific gene. The MT1531 gene also does not
appear to be the result of gene transfer according to our findings.
We have examined a number of genes in the pathway for
evidence of lineage-specific adaptive evolution and have con-
firmed the presence of selective pressures for amino acid change
in two of the gene families in this pathway. In other words, the
strains of M. tuberculosis that possessed specific changes in these
genes were at an advantage compared with strains that did not
have these changes.
The first gene in which we see adaptive evolution is that in
which there is only one member of the gene family in M.
tuberculosis. This is the acetyl-CoA carobxylase, which repre-
sents the first step in the pathway. The genes are very similar to
-proteobacterial genes, appear to have been acquired by the
actinobacteria, and have been extensively modified in the my-
cobacteria. In the case of one of the oxidoreductase genes (Figs.
1F and 4), we see evidence of gene family expansion by
duplication followed by positive selection in one of the genes.
This is likely to be a kind of ‘‘tweaking’’ of the mechanism of fatty
acid synthesis, perhaps for improved functioning after major
alterations of the pathway.
Fig. 5. Phylogenetic tree inferred from enoyl (acp) reductase genes. This tree
corresponds to Fig. 1G. The numbers on the internal branches are Bayesian
clade credibility values. The arrow indicates the branch that was analyzed for
signatures indicative of adaptive evolution.
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The codon usage pattern for the genes involved in fatty acid
biosynthesis is typical of the remainder of the genes in the
genome. It was found that those genes that had the least
similarity of codon usage to the majority of tuberculosis genes
were the PE and PPE family of proteins, as was previously found
to be the case in the H37Rv strain (42). The absence of any
appreciable difference in synonymous codon usage between
putative recent acquisitions and the rest of the genome can be for
either of two reasons. The incoming genes could have had a
codon usage pattern very similar to the average pattern in the
CDC1551 strain, or perhaps enough time has elapsed since
acquisition of these genes that mutational pressure has caused
these genes to ameliorate toward the typical CDC1551 codon
usage pattern.
In summary, this ancient pathway has been extensively mod-
ified in M. tuberculosis, with HGT, duplication, and adaptive
evolution contributing to these modifications. These results
should help explain why M. tuberculosis is so accomplished at
working with fatty acids.
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